Stockchase Research
Member since: Jul '20
Michael O'Reilley at
Stockchase
Stockchase
82 Opinions
Latest Top Picks
Stockchase Research Editor: Michael O'Reilly As the market valuations continue to be priced at perfection this is a defensive Top Pick. This low MER ETF tracks US 7-10 year Treasuries -- a safe haven during market down turns. What makes this interesting as well, from an Canadian investor's perspective, is that it is priced in Canadian dollars. This will add another kicker in a market down turn as we expect a flight to the US dollar safety at some point. We would buy this with a $60 stop-loss. Yield 0%
Stockchase Research Editor: Michael O'Reilly MRK is one of the largest pharma companies in the world. It trades at a 13 PE compared to 22 PE for the S&P500. The pandemic has slowed some elective procedures, and that has slowed sales in the latest quarter by about 9%. However, management still opted to raise its 2020 guidance showing confidence that things should improve for the balance of the year. The company also has three drugs moving through various COVID-19 vaccine test trials. It pays a good yield, backed by a 58% payout ratio. We would buy this with an upper target towards $96 as the first objective and use $77 as a stop-loss. Yield 2.95% (Analysts’ price target is $95.94)
Stockchase Research Editor: Michael O'Reilly In the search for a pandemic vaccine, JNJ is a potential winner. Leveraging off their proven technology with their Ebola, HIV and other vaccines, the company continues to develop a COVID-19 vaccine that presently shows strong immunity response in 99% of trials. It is also the only option that is testing a single-dose vaccine. Revenues have dipped 10% in the latest quarterly earnings, but that can be attributed to a slow down in elective procedures. It pays a good dividend backed by a 67% payout ratio. We would trade this with a stop-loss at $132. Yield 2.75% (Analysts’ price target is $165.06)
Stockchase Research Editor: Michael O'Reilly We are being rewarded for our patience and are making MMM a Top Pick following a recent pullback in the stock. As previously reported, the maker of the N95 masks has been in the spot light as they have directly been keeping front line workers safer during the pandemic. For 2020 they expect to have produced 2 billion of the masks and continue to partner with the US Department of Defense. The company is mulling over selling the food safety business for $3.5 billion -- 10 times annual revenues of the segment. The segment contributed 1% of total sales in 2019. Their health care segment is expected to pick up as well, after seeing a 12% yoy slowdown, as delays in elective procedures are removed. It has an attractive yield that is backed by a payout ratio of 65% of cash flow. We look for this to test $185 and would use $149 as a stop-loss. Yield 3.69% (Analysts’ price target is $166.47)
(A Top Pick Aug 11/20, Down 9.3%)Stochchase Research Editor: Michael O'Reilly We have recommended to stop out of EPD as it has violated the $16.50 threshold we recommended. We see technical indications that the stock could retrace to $12. We will look for better opportunities elsewhere.
Signal
Opinion
Expert
Chart
TOP PICK
TOP PICK
September 29, 2020
Stockchase Research Editor: Michael O'Reilly As the market valuations continue to be priced at perfection this is a defensive Top Pick. This low MER ETF tracks US 7-10 year Treasuries -- a safe haven during market down turns. What makes this interesting as well, from an Canadian investor's perspective, is that it is priced in Canadian dollars. This will add another kicker in a market down turn as we expect a flight to the US dollar safety at some point. We would buy this with a $60 stop-loss. Yield 0%
Show full opinionHide full opinion
Stockchase Research Editor: Michael O'Reilly As the market valuations continue to be priced at perfection this is a defensive Top Pick. This low MER ETF tracks US 7-10 year Treasuries -- a safe haven during market down turns. What makes this interesting as well, from an Canadian investor's perspective, is that it is priced in Canadian dollars. This will add another kicker in a market down turn as we expect a flight to the US dollar safety at some point. We would buy this with a $60 stop-loss. Yield 0%
E.T.F.'s
TOP PICK
TOP PICK
September 29, 2020
Stockchase Research Editor: Michael O'Reilly MRK is one of the largest pharma companies in the world. It trades at a 13 PE compared to 22 PE for the S&P500. The pandemic has slowed some elective procedures, and that has slowed sales in the latest quarter by about 9%. However, management still opted to raise its 2020 guidance showing confidence that things should improve for the balance of the year. The company also has three drugs moving through various COVID-19 vaccine test trials. It pays a good yield, backed by a 58% payout ratio. We would buy this with an upper target towards $96 as the first objective and use $77 as a stop-loss. Yield 2.95% (Analysts’ price target is $95.94)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly MRK is one of the largest pharma companies in the world. It trades at a 13 PE compared to 22 PE for the S&P500. The pandemic has slowed some elective procedures, and that has slowed sales in the latest quarter by about 9%. However, management still opted to raise its 2020 guidance showing confidence that things should improve for the balance of the year. The company also has three drugs moving through various COVID-19 vaccine test trials. It pays a good yield, backed by a 58% payout ratio. We would buy this with an upper target towards $96 as the first objective and use $77 as a stop-loss. Yield 2.95% (Analysts’ price target is $95.94)
biotechnology/pharmaceutical
TOP PICK
TOP PICK
September 29, 2020
Stockchase Research Editor: Michael O'Reilly In the search for a pandemic vaccine, JNJ is a potential winner. Leveraging off their proven technology with their Ebola, HIV and other vaccines, the company continues to develop a COVID-19 vaccine that presently shows strong immunity response in 99% of trials. It is also the only option that is testing a single-dose vaccine. Revenues have dipped 10% in the latest quarterly earnings, but that can be attributed to a slow down in elective procedures. It pays a good dividend backed by a 67% payout ratio. We would trade this with a stop-loss at $132. Yield 2.75% (Analysts’ price target is $165.06)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly In the search for a pandemic vaccine, JNJ is a potential winner. Leveraging off their proven technology with their Ebola, HIV and other vaccines, the company continues to develop a COVID-19 vaccine that presently shows strong immunity response in 99% of trials. It is also the only option that is testing a single-dose vaccine. Revenues have dipped 10% in the latest quarterly earnings, but that can be attributed to a slow down in elective procedures. It pays a good dividend backed by a 67% payout ratio. We would trade this with a stop-loss at $132. Yield 2.75% (Analysts’ price target is $165.06)
biotechnology/pharmaceutical
TOP PICK
TOP PICK
September 24, 2020
Stockchase Research Editor: Michael O'Reilly We are being rewarded for our patience and are making MMM a Top Pick following a recent pullback in the stock. As previously reported, the maker of the N95 masks has been in the spot light as they have directly been keeping front line workers safer during the pandemic. For 2020 they expect to have produced 2 billion of the masks and continue to partner with the US Department of Defense. The company is mulling over selling the food safety business for $3.5 billion -- 10 times annual revenues of the segment. The segment contributed 1% of total sales in 2019. Their health care segment is expected to pick up as well, after seeing a 12% yoy slowdown, as delays in elective procedures are removed. It has an attractive yield that is backed by a payout ratio of 65% of cash flow. We look for this to test $185 and would use $149 as a stop-loss. Yield 3.69% (Analysts’ price target is $166.47)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly We are being rewarded for our patience and are making MMM a Top Pick following a recent pullback in the stock. As previously reported, the maker of the N95 masks has been in the spot light as they have directly been keeping front line workers safer during the pandemic. For 2020 they expect to have produced 2 billion of the masks and continue to partner with the US Department of Defense. The company is mulling over selling the food safety business for $3.5 billion -- 10 times annual revenues of the segment. The segment contributed 1% of total sales in 2019. Their health care segment is expected to pick up as well, after seeing a 12% yoy slowdown, as delays in elective procedures are removed. It has an attractive yield that is backed by a payout ratio of 65% of cash flow. We look for this to test $185 and would use $149 as a stop-loss. Yield 3.69% (Analysts’ price target is $166.47)
mngmnt/diversified
PAST TOP PICK
PAST TOP PICK
September 24, 2020
(A Top Pick Aug 11/20, Down 9.3%)Stochchase Research Editor: Michael O'Reilly We have recommended to stop out of EPD as it has violated the $16.50 threshold we recommended. We see technical indications that the stock could retrace to $12. We will look for better opportunities elsewhere.
Show full opinionHide full opinion(A Top Pick Aug 11/20, Down 9.3%)Stochchase Research Editor: Michael O'Reilly We have recommended to stop out of EPD as it has violated the $16.50 threshold we recommended. We see technical indications that the stock could retrace to $12. We will look for better opportunities elsewhere.
TOP PICK
TOP PICK
September 24, 2020
Stochchase Research Editor: Michael O'Reilly PFE is a defensive Top Pick that pays a strong yield, with history of dividend growth and a strong balance sheet. It is one of the world's leading pharmaceutical companies with a robust pipeline of new products in development (targeting 25 new drugs to market by 2025). They are partnering to develop a COVID-19 vaccine that is now in stage 2/3 testing and has a contract with the US government for $1.95 billion for the first 100 million doses if successful. The company holds $1.8 billion in cash reserves. The yield is strong and is supported with a 58% payout ratio. We would buy this using a $31 stop-loss, looking for a return towards $42. Yield 4.22% (Analysts’ price target is $41.79)
Show full opinionHide full opinionStochchase Research Editor: Michael O'Reilly PFE is a defensive Top Pick that pays a strong yield, with history of dividend growth and a strong balance sheet. It is one of the world's leading pharmaceutical companies with a robust pipeline of new products in development (targeting 25 new drugs to market by 2025). They are partnering to develop a COVID-19 vaccine that is now in stage 2/3 testing and has a contract with the US government for $1.95 billion for the first 100 million doses if successful. The company holds $1.8 billion in cash reserves. The yield is strong and is supported with a 58% payout ratio. We would buy this using a $31 stop-loss, looking for a return towards $42. Yield 4.22% (Analysts’ price target is $41.79)
biotechnology/pharmaceutical
TOP PICK
TOP PICK
September 24, 2020
Stochchase Research Editor: Michael O'Reilly As the pandemic appears to be heading towards wave two, take-out vendors will continue to benefit. PZZA has done well thus far, with recently reported revenues rising by 15% over the year and sales up 28%. We recommend picking up this Top Pick with an eye to return return to $100 -- nearly a 20% return-- using $72 as stop-loss. Yield 1.05% (Analysts’ price target is $106.21)
Show full opinionHide full opinionStochchase Research Editor: Michael O'Reilly As the pandemic appears to be heading towards wave two, take-out vendors will continue to benefit. PZZA has done well thus far, with recently reported revenues rising by 15% over the year and sales up 28%. We recommend picking up this Top Pick with an eye to return return to $100 -- nearly a 20% return-- using $72 as stop-loss. Yield 1.05% (Analysts’ price target is $106.21)
food services
TOP PICK
TOP PICK
September 22, 2020
Stockchase Research Editor: Michael O'Reilly eCommerce trade has benefitted during the pandemic and this is one of the major companies that delivers the goods. UPS just received an upgrade by analysts at Credit Suisse,. It is a defensive holding that continues to see revenues growing by double-digits. It pays a good dividend backed by a decent payout ratio. The technical chart is setting up for another push higher. We would trade this with a stop-loss at $145. Yield 2.51%
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly eCommerce trade has benefitted during the pandemic and this is one of the major companies that delivers the goods. UPS just received an upgrade by analysts at Credit Suisse,. It is a defensive holding that continues to see revenues growing by double-digits. It pays a good dividend backed by a decent payout ratio. The technical chart is setting up for another push higher. We would trade this with a stop-loss at $145. Yield 2.51%
Transportation
TOP PICK
TOP PICK
September 22, 2020
Stockchase Research Editor: Michael O'Reilly NOC is a security company providing products like autonomous systems and cybersecurity and it operates in the US, Asia-Pacific and internationally. It has over $70 billion in backlog orders, which are principally with government agencies like the US Defense department. Recent earnings were up 19% with a 53% increase in free cash flow and the company increased its earnings guidance. We would trade this with a stop-loss at $295. Yield 1.78% (Analysts’ price target is $393.18)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly NOC is a security company providing products like autonomous systems and cybersecurity and it operates in the US, Asia-Pacific and internationally. It has over $70 billion in backlog orders, which are principally with government agencies like the US Defense department. Recent earnings were up 19% with a 53% increase in free cash flow and the company increased its earnings guidance. We would trade this with a stop-loss at $295. Yield 1.78% (Analysts’ price target is $393.18)
Transportation
TOP PICK
TOP PICK
September 22, 2020
Stockchase Research Editor: Michael O'Reilly With the recent pullback from $150 highs, this is a good opportunity to enter. Rising revenues, profit margins and EPS are propelling this company, which has been an essential service provider during the pandemic. As retail bankruptcies rise in the US, there is a growing gap for WMT to fill. Dividends have grown for 47 consecutive years and are backed by a 34% payout ratio. We would buy this with a stop-loss at $120. Yield 1.58% (Analysts’ price target is $145.88)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly With the recent pullback from $150 highs, this is a good opportunity to enter. Rising revenues, profit margins and EPS are propelling this company, which has been an essential service provider during the pandemic. As retail bankruptcies rise in the US, there is a growing gap for WMT to fill. Dividends have grown for 47 consecutive years and are backed by a 34% payout ratio. We would buy this with a stop-loss at $120. Yield 1.58% (Analysts’ price target is $145.88)
department stores
BUY WEAKNESS
BUY WEAKNESS
September 17, 2020
Stockchase Research Editor: Michael O'Reilly The maker of the N95 masks has been in the spot light as they have directly been keeping front line workers safer during the pandemic. For 2020 they expect to have produced 2 billion of the masks and continue to partner with the US Department of Defense. The automotive OEM business has struggled with sales down 44% during the pandemic, but analysts expect that to rebound and that could have a sizable impact to the bottom line. Their health care segment is expected to pick up as well, after seeing a 12% yoy slowdown, as delays in elective procedures are removed. It has an attractive yield that is backed by a payout ratio of 65% of cash flow. We like the technical breakout recently and look for this Top Pick to test $185. We would like to buy on a pullback to $160 -- looking for over 15% upside. Yield 3.47%
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly The maker of the N95 masks has been in the spot light as they have directly been keeping front line workers safer during the pandemic. For 2020 they expect to have produced 2 billion of the masks and continue to partner with the US Department of Defense. The automotive OEM business has struggled with sales down 44% during the pandemic, but analysts expect that to rebound and that could have a sizable impact to the bottom line. Their health care segment is expected to pick up as well, after seeing a 12% yoy slowdown, as delays in elective procedures are removed. It has an attractive yield that is backed by a payout ratio of 65% of cash flow. We like the technical breakout recently and look for this Top Pick to test $185. We would like to buy on a pullback to $160 -- looking for over 15% upside. Yield 3.47%
mngmnt/diversified
TOP PICK
TOP PICK
September 17, 2020
Stockchase Research Editor: Michael O'Reilly XRX has been a laggard during the pandemic as office workers have been remotely working. As employees begin a return to the office environment demand for the company's products will begin to return. Meanwhile the stock is quietly building a solid foundation. Carl Icahn has been accumulating shares steadily through August and purchased another $3 million worth of the stock so far in September. In its latest earnings the company produced $0.15 EPS, when analysts expected a breakeven, even in the face of a 35% drop in revenues. An area of future growth is in their liquid metal 3D printing solution -- allowing companies to manufacture much needed parts with off the shelf alloys. On a measured move basis, we see upside to $25 -- almost 30% upside. It is trading at 74% of book value, with a low historic PE, and offers an attractive yield that is backed by a 28% payout ratio. We would trade this with a $15 stop loss. Yield 5.20% (Analysts’ price target is $18.25)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly XRX has been a laggard during the pandemic as office workers have been remotely working. As employees begin a return to the office environment demand for the company's products will begin to return. Meanwhile the stock is quietly building a solid foundation. Carl Icahn has been accumulating shares steadily through August and purchased another $3 million worth of the stock so far in September. In its latest earnings the company produced $0.15 EPS, when analysts expected a breakeven, even in the face of a 35% drop in revenues. An area of future growth is in their liquid metal 3D printing solution -- allowing companies to manufacture much needed parts with off the shelf alloys. On a measured move basis, we see upside to $25 -- almost 30% upside. It is trading at 74% of book value, with a low historic PE, and offers an attractive yield that is backed by a 28% payout ratio. We would trade this with a $15 stop loss. Yield 5.20% (Analysts’ price target is $18.25)
misc industrial products
TOP PICK
TOP PICK
September 17, 2020
Stockchase Research Editor: Michael O'Reilly We are once again cautioning against a possible market retracement and are recommending this inverse S&P500 ETF as a Top Pick. As it is priced in Canadian dollars it will receive added benefit from a weakening in the Canadian dollar if the market retraces. We recommend this as a hedge against dividend paying stocks. It has a very low MER as well.
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly We are once again cautioning against a possible market retracement and are recommending this inverse S&P500 ETF as a Top Pick. As it is priced in Canadian dollars it will receive added benefit from a weakening in the Canadian dollar if the market retraces. We recommend this as a hedge against dividend paying stocks. It has a very low MER as well.
E.T.F.'s
TOP PICK
TOP PICK
September 17, 2020
Stockchase Research Editor: Michael O'Reilly Thus utilities based ETF is a defensive holding that provides a solid yield. This can act as a hedge against investor equity holding in case of a broad market retracement. Utility holdings also benefit during a prolonged low interest rate environment. We would trade this with a $54 stop-loss.
Yield 3.38%
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly Thus utilities based ETF is a defensive holding that provides a solid yield. This can act as a hedge against investor equity holding in case of a broad market retracement. Utility holdings also benefit during a prolonged low interest rate environment. We would trade this with a $54 stop-loss.
Yield 3.38%
E.T.F.'s
PAST TOP PICK
PAST TOP PICK
September 17, 2020
(A Top Pick Aug 25/20, Up 44%) When we recommended this furniture manufacturing company we picked $21 as an upper target. It has smoothly moved through that target. We are now recommending to trail up the stop-loss to $21, looking to cover half of the position should there be a pullback in the stock price.
Show full opinionHide full opinion(A Top Pick Aug 25/20, Up 44%) When we recommended this furniture manufacturing company we picked $21 as an upper target. It has smoothly moved through that target. We are now recommending to trail up the stop-loss to $21, looking to cover half of the position should there be a pullback in the stock price.
Consumer Products
TOP PICK
TOP PICK
September 15, 2020
Stockchase Research Editor: Michael O'Reilly BANF operates 107 commercial banking locations in Oklahoma. Its latest earnings report topped analyst expectations by over 30% and it achieves margins over 23%. EPS has grown on average 8.9% annually over the past five years. The dividend was just raised and pays a decent yield that is backed by a 37% payout ratio. We would trade this with a stop-loss at $39.00. Yield 3.03% (Analysts’ price target is $66.00)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly BANF operates 107 commercial banking locations in Oklahoma. Its latest earnings report topped analyst expectations by over 30% and it achieves margins over 23%. EPS has grown on average 8.9% annually over the past five years. The dividend was just raised and pays a decent yield that is backed by a 37% payout ratio. We would trade this with a stop-loss at $39.00. Yield 3.03% (Analysts’ price target is $66.00)
banks
TOP PICK
TOP PICK
September 15, 2020
Stockchase Research Editor: Michael O'Reilly It will soon be tax time again and HRB is set to see a seasonal uptick in business. Latest earnings beat expectations by almost 50%. Although EPS was negative the company's investment in its online digital platform will better position it for this pandemic based economy. It pays a nice dividend, but its payout ratio of cash flow is a bit high at 84% -- we think improving earnings will keep it safe. We expect some technical resistance near $17, when breached will lead to a test of $20 -- 35% upside. We would trade this with a $13 stop-loss. Yield 7.07% (Analysts’ price target is $20.17)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly It will soon be tax time again and HRB is set to see a seasonal uptick in business. Latest earnings beat expectations by almost 50%. Although EPS was negative the company's investment in its online digital platform will better position it for this pandemic based economy. It pays a nice dividend, but its payout ratio of cash flow is a bit high at 84% -- we think improving earnings will keep it safe. We expect some technical resistance near $17, when breached will lead to a test of $20 -- 35% upside. We would trade this with a $13 stop-loss. Yield 7.07% (Analysts’ price target is $20.17)
other services
TOP PICK
TOP PICK
September 15, 2020
Stockchase Research Editor: Michael O'Reilly UGI distributes energy, primarily propane, to over 1.7 million customers through 1900 distribution locations in the US. This is a bit of a seasonal play as their business is getting busy now shipping energy to its customers ahead of winter. It pays a nice dividend that is backed by a payout ratio of only 57% of cash flow. We would trade this with a stop-loss of $30, looking for a return to $45 -- 35% upside. Yield 4.05% (Analysts’ price target is $45.25)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly UGI distributes energy, primarily propane, to over 1.7 million customers through 1900 distribution locations in the US. This is a bit of a seasonal play as their business is getting busy now shipping energy to its customers ahead of winter. It pays a nice dividend that is backed by a payout ratio of only 57% of cash flow. We would trade this with a stop-loss of $30, looking for a return to $45 -- 35% upside. Yield 4.05% (Analysts’ price target is $45.25)
Energy Infrastructure, Industrials & Utilities
PAST TOP PICK
PAST TOP PICK
September 15, 2020
(A Top Pick Aug 25/20, Up 18%)Stockchase Research Editor: Michael O'Reilly We set $35 as an upper objective for FL as a Top Pick and we have achieved that target. Goldman Sachs just initiated coverage on the company and set a $38 target so we will let our winner run. However, we are suggesting taking 50% of the position off the table. We also recommend trailing up to stop-loss to $26.50. Based on a measured technical move, we would now target $44 as our next upper objective.
(A Top Pick Aug 25/20, Up 18%)Stockchase Research Editor: Michael O'Reilly We set $35 as an upper objective for FL as a Top Pick and we have achieved that target. Goldman Sachs just initiated coverage on the company and set a $38 target so we will let our winner run. However, we are suggesting taking 50% of the position off the table. We also recommend trailing up to stop-loss to $26.50. Based on a measured technical move, we would now target $44 as our next upper objective.
clothing stores
TOP PICK
TOP PICK
September 10, 2020
Stockchase Research Editor: Michael O'Reilly The company is a regional bank and trust company operating in Pennsylvania. It’s recently posted earnings and stock price put the PE at 12.5, well under sector and market levels. It is also trading at less than 70% of book value. Earnings for 2021 are expected to grow by over 40%. We like the dividend yield, which has only a 65% payout ratio. We would trade this with a $14 stop-loss. Yield 5.07% (Analysts’ price target is $19.75)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly The company is a regional bank and trust company operating in Pennsylvania. It’s recently posted earnings and stock price put the PE at 12.5, well under sector and market levels. It is also trading at less than 70% of book value. Earnings for 2021 are expected to grow by over 40%. We like the dividend yield, which has only a 65% payout ratio. We would trade this with a $14 stop-loss. Yield 5.07% (Analysts’ price target is $19.75)
Financial Services
TOP PICK
TOP PICK
September 10, 2020
Stockchase Research Editor: Michael O'Reilly MTG provides mortgage insurance in the US, Puerto Rico and Guam. The company released an operational update to end-August indicating the inventory of delinquent loans continues to decrease, with the % of new delinquency notices dropping by over 25% since June. It trades at 69% of book value and EPS is expected to grow to $1.50 per share from $1.44 this year. While still levered to an economic recovery, we make this a Top Pick. The yield is supported by a payout ratio of less than 10% of cash flow. We would trade buy this with a $7.00 stop-loss. Yield 2.69% (Analysts’ price target is $12.43)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly MTG provides mortgage insurance in the US, Puerto Rico and Guam. The company released an operational update to end-August indicating the inventory of delinquent loans continues to decrease, with the % of new delinquency notices dropping by over 25% since June. It trades at 69% of book value and EPS is expected to grow to $1.50 per share from $1.44 this year. While still levered to an economic recovery, we make this a Top Pick. The yield is supported by a payout ratio of less than 10% of cash flow. We would trade buy this with a $7.00 stop-loss. Yield 2.69% (Analysts’ price target is $12.43)
finance/leasing
TOP PICK
TOP PICK
September 10, 2020
Stockchase Research Editor: Michael O'Reilly The company provides personal and commercial residential insurance through the Atlantic coast and Alabama and expanding into Mississippi. Recent annual earnings showed a 10% increase in revenues and EPS has grown to $0.42 per share from a 2019 average of $0.02. Analysts look for EPS to grow over 40% next year. It trades at 83% of book value. It pays a small dividend that is well supported by cashflow. We would trade this with a $11.50 stop-loss. Yield 1.94% (Analysts’ price target is $17.00)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly The company provides personal and commercial residential insurance through the Atlantic coast and Alabama and expanding into Mississippi. Recent annual earnings showed a 10% increase in revenues and EPS has grown to $0.42 per share from a 2019 average of $0.02. Analysts look for EPS to grow over 40% next year. It trades at 83% of book value. It pays a small dividend that is well supported by cashflow. We would trade this with a $11.50 stop-loss. Yield 1.94% (Analysts’ price target is $17.00)
insurance
PAST TOP PICK
PAST TOP PICK
September 8, 2020
(A Top Pick Aug 27/20, Down 12%)Stockchase Research Editor: Michael O'Reilly We are choosing to remain disciplined and stick to our stop-loss at $35 and look for better alternatives. Now that key technical support has been breached it could try to retest lows near $25.
Show full opinionHide full opinion(A Top Pick Aug 27/20, Down 12%)Stockchase Research Editor: Michael O'Reilly We are choosing to remain disciplined and stick to our stop-loss at $35 and look for better alternatives. Now that key technical support has been breached it could try to retest lows near $25.
TOP PICK
TOP PICK
September 8, 2020
Stockchase Research Editor: Michael O'Reilly We are being rewarded for being patient. We suggested to buy this on weakness on a pullback. CNR recently reported earnings and the stock jumped over 20%. EPS increased 50% to $0.21 per share (including a sizable tax gain), when the market was expecting a net loss and the company has a record order backlog. The company designs and manufacturers building products for non-residential construction, siding and windows. We would trade this with a stop-loss at $6.50, with a target to revisit $9.50 (25% upside). Yield 0% (Analysts’ price target is $10.51)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly We are being rewarded for being patient. We suggested to buy this on weakness on a pullback. CNR recently reported earnings and the stock jumped over 20%. EPS increased 50% to $0.21 per share (including a sizable tax gain), when the market was expecting a net loss and the company has a record order backlog. The company designs and manufacturers building products for non-residential construction, siding and windows. We would trade this with a stop-loss at $6.50, with a target to revisit $9.50 (25% upside). Yield 0% (Analysts’ price target is $10.51)
wholesale distributors
TOP PICK
TOP PICK
September 8, 2020
Stockchase Research Editor: Michael O'Reilly We are being rewarded for our patience as this was a buy on weakness target. An obvious household name, K often gets over looked, but it is proving to be a survivor. The company just upgraded its annual sales and profit guidance for the year as organic net sales are up 9% on the quarter. EPS beat analyst expectations by 32%. We like the dividend and feel it is secure. We would use $60 as a stop loss. Yield 3.29% (Analysts’ price target is $71.79)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly We are being rewarded for our patience as this was a buy on weakness target. An obvious household name, K often gets over looked, but it is proving to be a survivor. The company just upgraded its annual sales and profit guidance for the year as organic net sales are up 9% on the quarter. EPS beat analyst expectations by 32%. We like the dividend and feel it is secure. We would use $60 as a stop loss. Yield 3.29% (Analysts’ price target is $71.79)
food processing
TOP PICK
TOP PICK
September 8, 2020
Stockchase Research Editor: Michael O'Reilly We are being rewarded for our patience as this was a buy on weakness target. The company best known for jam, also provides pet foods, coffee and much more. Its recent earnings were so strong the company has increased its guidance for 2021. Management projects $8.20-$8.60 EPS, up from $7.90-$8.30 for next year. Recent earnings of $2.37 per share beat estimates of $1.67. It pays a good dividend with a 51% payout ratio. We would buy this with a stop-loss at $103. Yield 3.06% (Analysts’ price target is $117.40)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly We are being rewarded for our patience as this was a buy on weakness target. The company best known for jam, also provides pet foods, coffee and much more. Its recent earnings were so strong the company has increased its guidance for 2021. Management projects $8.20-$8.60 EPS, up from $7.90-$8.30 for next year. Recent earnings of $2.37 per share beat estimates of $1.67. It pays a good dividend with a 51% payout ratio. We would buy this with a stop-loss at $103. Yield 3.06% (Analysts’ price target is $117.40)
food processing
PAST TOP PICK
PAST TOP PICK
September 8, 2020
(A Top Pick Aug 04/20, Down 12%) We are going to be disciplined and recommend this position be covered. With breach of keep technical support at $200 last week and further follow through this week, it is prudent to cover. There are now growing concerns of China-US trade tensions expanding into semiconductor manufacturers.
Show full opinionHide full opinion(A Top Pick Aug 04/20, Down 12%) We are going to be disciplined and recommend this position be covered. With breach of keep technical support at $200 last week and further follow through this week, it is prudent to cover. There are now growing concerns of China-US trade tensions expanding into semiconductor manufacturers.
electrical/electronic
TOP PICK
TOP PICK
September 3, 2020
Stockchase Research Editor: Michael O'Reilly This is a financial services technology company with business worldwide. It provides mobile e-commerce services direct to the consumer. They just partnered with Amazon and ExxonMobil to develop "Alexa, pay for gas" service now in place at 11,500 Exxon and Mobil stations in the US. There are 22 analysts with a buy rating presently and it is held by 85 hedge funds. Technically, the stock has shown momentum that could see a re-test of $109 soon and then a move to analyst expectations of $125 -- 25% upside. We would buy this with a relatively tight stop-loss at $194. Yield 0% (Analysts’ price target is $125.41)
Stockchase Research Editor: Michael O'Reilly This is a financial services technology company with business worldwide. It provides mobile e-commerce services direct to the consumer. They just partnered with Amazon and ExxonMobil to develop "Alexa, pay for gas" service now in place at 11,500 Exxon and Mobil stations in the US. There are 22 analysts with a buy rating presently and it is held by 85 hedge funds. Technically, the stock has shown momentum that could see a re-test of $109 soon and then a move to analyst expectations of $125 -- 25% upside. We would buy this with a relatively tight stop-loss at $194. Yield 0% (Analysts’ price target is $125.41)
Financial Services
TOP PICK
TOP PICK
September 3, 2020
Stockchase Research Editor: Michael O'Reilly As markets appear ready to see at least some profit taking for the next while, we are again encouraging a defensive holding to protect against a sizable market retracement. HIU is an inverse ETF of the S&P500 Index that trades in Canadian dollars. This allows investors to continue holding dividend paying investments in the event of market erosion. We would expect the Canadian dollar to weaken relative to the US greenback in a market pull back, to there will be an added kicker to the return. Yield 0%
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly As markets appear ready to see at least some profit taking for the next while, we are again encouraging a defensive holding to protect against a sizable market retracement. HIU is an inverse ETF of the S&P500 Index that trades in Canadian dollars. This allows investors to continue holding dividend paying investments in the event of market erosion. We would expect the Canadian dollar to weaken relative to the US greenback in a market pull back, to there will be an added kicker to the return. Yield 0%
E.T.F.'s
PAST TOP PICK
PAST TOP PICK
September 3, 2020
(A Top Pick Aug 20/20, Down 12.1%)Stockchase Research Editor: Michael O'Reilly Based on a the breakdown below our stop-loss of $95 we are recommending this position be covered. This is not so much a change in company fundamentals, as it is in the possibility of further general market weakness. We see better opportunities in the market.
Show full opinionHide full opinion(A Top Pick Aug 20/20, Down 12.1%)Stockchase Research Editor: Michael O'Reilly Based on a the breakdown below our stop-loss of $95 we are recommending this position be covered. This is not so much a change in company fundamentals, as it is in the possibility of further general market weakness. We see better opportunities in the market.
Automotive
PAST TOP PICK
PAST TOP PICK
September 3, 2020
(A Top Pick Aug 06/20, Down 5.29%)Stockchase Research Editor: Michael O'Reilly We are following recommending to cover any holding in PANW as we have breached the $250 stop-loss threshold we set. Market conditions are changing and we are choosing to remain disciplined and seek opportunities elsewhere.
Show full opinionHide full opinion(A Top Pick Aug 06/20, Down 5.29%)Stockchase Research Editor: Michael O'Reilly We are following recommending to cover any holding in PANW as we have breached the $250 stop-loss threshold we set. Market conditions are changing and we are choosing to remain disciplined and seek opportunities elsewhere.
TOP PICK
TOP PICK
September 3, 2020
Stockchase Research Editor: Michael O'Reilly BG operates as a agribusiness and food company worldwide. It is well diversified into five segments: agribusiness, edible oil, milling, sugar and bioenergy, and fertilizer. Recent reported EPS of $3.88, beat expectations of $1.31. Earnings growth is expected over 20% next year. It pays a nice dividend with a 44% payout ratio. Analysts see upside towards $61 -- over 30% upside. We would buy this now with a stop-loss at $38. Yield 4.40% (Analysts’ price target is $61.13)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly BG operates as a agribusiness and food company worldwide. It is well diversified into five segments: agribusiness, edible oil, milling, sugar and bioenergy, and fertilizer. Recent reported EPS of $3.88, beat expectations of $1.31. Earnings growth is expected over 20% next year. It pays a nice dividend with a 44% payout ratio. Analysts see upside towards $61 -- over 30% upside. We would buy this now with a stop-loss at $38. Yield 4.40% (Analysts’ price target is $61.13)
agriculture
TOP PICK
TOP PICK
September 1, 2020
PE is an independent oil and gas producer in the Permian. EPS is expected to grow by 56% in the coming year and it trades at 52% of book value. There are currently 21 buy ratings on the company. It latest earnings reported $0.03 EPS versus consensus of of ($0.14). Plus it pays a reasonable dividend. We would trade this with an $8 stop-loss. At current prices this over 40% of upside. Yield 1.86% (Analysts’ price target is $15.83)
Show full opinionHide full opinionPE is an independent oil and gas producer in the Permian. EPS is expected to grow by 56% in the coming year and it trades at 52% of book value. There are currently 21 buy ratings on the company. It latest earnings reported $0.03 EPS versus consensus of of ($0.14). Plus it pays a reasonable dividend. We would trade this with an $8 stop-loss. At current prices this over 40% of upside. Yield 1.86% (Analysts’ price target is $15.83)
Energy
TOP PICK
TOP PICK
September 1, 2020
OMF is involved in consumer credit and provides involuntary unemployment insurance as well as auto membership plans in 44 US states. It beat last earnings estimates by $0.58 per share when it reported $0.80. Currently there are 15 buy ratings and EPS are expected to grow by 50% next year. With a PE of only 6.3, it is cheap compared to industry peers averaging 19. It is only trading at 92% of book value. It pays a good dividend that is backed by a low payout ratio of less than 20% of cash flow. We would buy this with a $21 stop-loss and see potentially over 40% upside. Yield 4.6% (Analysts’ price target is $41.20)
Show full opinionHide full opinionOMF is involved in consumer credit and provides involuntary unemployment insurance as well as auto membership plans in 44 US states. It beat last earnings estimates by $0.58 per share when it reported $0.80. Currently there are 15 buy ratings and EPS are expected to grow by 50% next year. With a PE of only 6.3, it is cheap compared to industry peers averaging 19. It is only trading at 92% of book value. It pays a good dividend that is backed by a low payout ratio of less than 20% of cash flow. We would buy this with a $21 stop-loss and see potentially over 40% upside. Yield 4.6% (Analysts’ price target is $41.20)
Financial Services
TOP PICK
TOP PICK
September 1, 2020
NRZ has recently gone through a major transformation as a result of the pandemic and it has reduced the risk of the company dramatically by moving into only government secured mortgages. They completely exited all non-qualified mortgages. The company currently trades at 47% of book value. It has a good yield with only an 18% payout ratio. We see upside of over 60% and would trade this with a stop-loss of $6.50. Yield 5.06% (Analysts’ price target is $12.40)
Show full opinionHide full opinionNRZ has recently gone through a major transformation as a result of the pandemic and it has reduced the risk of the company dramatically by moving into only government secured mortgages. They completely exited all non-qualified mortgages. The company currently trades at 47% of book value. It has a good yield with only an 18% payout ratio. We see upside of over 60% and would trade this with a stop-loss of $6.50. Yield 5.06% (Analysts’ price target is $12.40)
Financial Services
PAST TOP PICK
PAST TOP PICK
September 1, 2020
(A Top Pick Aug 18/20, Down 18.6%) We chose to be disciplined and recommend exiting position as the $13.00 stop-loss was triggered last week. This follows the announcement by Abbott Labs for their successful emergency use authorization antibody test ahead of the GNMK proposal.
biotechnology/pharmaceutical
BUY WEAKNESS
BUY WEAKNESS
August 27, 2020
Stockchase Research Editor: Michael O'Reilly An e-commerce business in the country with the largest population on the planet. They are the second largest e-commerce company in China. Revenues were up 34% in Q2 hitting $9.1 billion. They have a strong logistics network and also offer cloud business and digital healthcare. The company is also forming strong partnerships, including Chinese based Tencent and Walmart. Barclay's just upgraded the stock to an $83 target. The stock had a great runup on the recent earnings report, so we would look to buy on a pullback towards $73. Yield 0%
Stockchase Research Editor: Michael O'Reilly An e-commerce business in the country with the largest population on the planet. They are the second largest e-commerce company in China. Revenues were up 34% in Q2 hitting $9.1 billion. They have a strong logistics network and also offer cloud business and digital healthcare. The company is also forming strong partnerships, including Chinese based Tencent and Walmart. Barclay's just upgraded the stock to an $83 target. The stock had a great runup on the recent earnings report, so we would look to buy on a pullback towards $73. Yield 0%
BUY WEAKNESS
BUY WEAKNESS
August 27, 2020
Stockchase Research Editor: Michael O'Reilly The company best known for jam, also provides pet foods, coffee and much more. Its recent earnings were so strong the company has increased its guidance for 2021. Management projects $8.20-$8.60 EPS, up from $7.90-$8.30 for next year. Recent earnings of $2.37 per share beat estimates of $1.67. This caused share prices to pop recently, so we would be looking to buy on a pullback towards $115. It pays a good dividend with a 51% payout ratio. Yield 2.96%
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly The company best known for jam, also provides pet foods, coffee and much more. Its recent earnings were so strong the company has increased its guidance for 2021. Management projects $8.20-$8.60 EPS, up from $7.90-$8.30 for next year. Recent earnings of $2.37 per share beat estimates of $1.67. This caused share prices to pop recently, so we would be looking to buy on a pullback towards $115. It pays a good dividend with a 51% payout ratio. Yield 2.96%
food processing
TOP PICK
TOP PICK
August 27, 2020
Stockchase Research Editor: Michael O'Reilly This discount retailer released strong earnings and continues to expand its business. In its earnings report released today EPS of $3.12 beat expectations of $2.47 and were up 92% from the previous year. Same store sales are up 15%. Management plans to complete a $2.5 billion share buyback by end-January. It pays a small dividend, but with a payout ratio of only 17% it is safe. We would trade this with a stop-loss of $189. Yield 0.71%
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly This discount retailer released strong earnings and continues to expand its business. In its earnings report released today EPS of $3.12 beat expectations of $2.47 and were up 92% from the previous year. Same store sales are up 15%. Management plans to complete a $2.5 billion share buyback by end-January. It pays a small dividend, but with a payout ratio of only 17% it is safe. We would trade this with a stop-loss of $189. Yield 0.71%
TOP PICK
TOP PICK
August 27, 2020
Stockchase Research Editor: Michael O'Reilly Trading at only 58% of book value this Permian oil producer is good value. Analysts are betting their realized oil price will be able to recover in the quarters ahead from the last reported $21.99 per barrel. The dividend is attractive as well. We would trade this with a $35 stop-loss, looking to see a recovery back to $58 -- a potential 48% gain. Yield 3.81% (Analysts’ price target is $58.59)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly Trading at only 58% of book value this Permian oil producer is good value. Analysts are betting their realized oil price will be able to recover in the quarters ahead from the last reported $21.99 per barrel. The dividend is attractive as well. We would trade this with a $35 stop-loss, looking to see a recovery back to $58 -- a potential 48% gain. Yield 3.81% (Analysts’ price target is $58.59)
TOP PICK
TOP PICK
August 27, 2020
Stockchase Research Editor: Michael O'Reilly This is an investment banking and capital markets company that directly invests in businesses in the Americas, Europe, the Middle East, Africa and Asia. It is trading at only 54% of book value. Its PE is only 75% of its earnings growth. These two factors make this a very undervalued company. Plus it pays a solid dividend with only a 40% payout ratio. We would buy this with a stop-loss at $14 looking for an upward target of $21.50 --
a 21% upside. Yield 3.42% (Analysts’ price target is $21.50)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly This is an investment banking and capital markets company that directly invests in businesses in the Americas, Europe, the Middle East, Africa and Asia. It is trading at only 54% of book value. Its PE is only 75% of its earnings growth. These two factors make this a very undervalued company. Plus it pays a solid dividend with only a 40% payout ratio. We would buy this with a stop-loss at $14 looking for an upward target of $21.50 --
a 21% upside. Yield 3.42% (Analysts’ price target is $21.50)
Financial Services
TOP PICK
TOP PICK
August 25, 2020
Stockchase Research Editor: Michael O'Reilly You might not expect a brick and mortar company like FL to be thriving during the pandemic, but we think it is poised for a sizable push higher. Recently released Q2 EPS were up over 7% from a year ago (EPS was $0.71 versus expecations of $0.57). Revenues increased 17%. The company was cautious early on during the pandemic and reduced the dividend, but we think there is good chance it will be increased before year end. We would buy this using $26 as a stop-loss and upper target of $35. Yield 2% (Analysts’ price target is $33.64)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly You might not expect a brick and mortar company like FL to be thriving during the pandemic, but we think it is poised for a sizable push higher. Recently released Q2 EPS were up over 7% from a year ago (EPS was $0.71 versus expecations of $0.57). Revenues increased 17%. The company was cautious early on during the pandemic and reduced the dividend, but we think there is good chance it will be increased before year end. We would buy this using $26 as a stop-loss and upper target of $35. Yield 2% (Analysts’ price target is $33.64)
clothing stores
TOP PICK
TOP PICK
August 25, 2020
Stockchase Research Editor: Michael O'Reilly UNH is the world's largest healthcare provider based on revenues. Its programs for Medicaid and Medicare added 600,000 members last year, revenues were up 7% and are expected to exceed $105 billion by 2022. A win by Vice President Biden this fall could be a real boon as more emphasis is put on improving the Affordable Health Care Act. The other major division, Optum, provides health data analytics. That segment saw a revenue increase over 16% in its recent earnings. It pays a nice dividend and has been increasing it for the past 11 years. We would use $280 as a stop-loss. Yield 1.62% (Analysts’ price target is $331.96)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly UNH is the world's largest healthcare provider based on revenues. Its programs for Medicaid and Medicare added 600,000 members last year, revenues were up 7% and are expected to exceed $105 billion by 2022. A win by Vice President Biden this fall could be a real boon as more emphasis is put on improving the Affordable Health Care Act. The other major division, Optum, provides health data analytics. That segment saw a revenue increase over 16% in its recent earnings. It pays a nice dividend and has been increasing it for the past 11 years. We would use $280 as a stop-loss. Yield 1.62% (Analysts’ price target is $331.96)
medical services
TOP PICK
TOP PICK
August 25, 2020
Stockchase Research Editor: Michael O'Reilly Consumers have been pent up in their homes and the trends appear towards making their nests more comfortable. FLXS is a well run furniture manufacturing company, that carries almost zero debt and has strong cash reserves. The company released earnings that were obviously impacted by the pandemic as the company chose to exit non-core businesses and focus on the higher margin items. However, some very bright spots included an 86% increase in ready-to-assemble products. The dividend was cut to preserve capital, so the yield is likely safe from here. The recent pullback in price affords a buy opportunity. We would trade this with stop-loss at $15 with an eye towards $21 -- over 20% upside. Yield 1.11%
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly Consumers have been pent up in their homes and the trends appear towards making their nests more comfortable. FLXS is a well run furniture manufacturing company, that carries almost zero debt and has strong cash reserves. The company released earnings that were obviously impacted by the pandemic as the company chose to exit non-core businesses and focus on the higher margin items. However, some very bright spots included an 86% increase in ready-to-assemble products. The dividend was cut to preserve capital, so the yield is likely safe from here. The recent pullback in price affords a buy opportunity. We would trade this with stop-loss at $15 with an eye towards $21 -- over 20% upside. Yield 1.11%
Consumer Products
BUY WEAKNESS
BUY WEAKNESS
August 25, 2020
Stockchase Research Editor: Michael O'Reilly This almost makes our Top Pick category. However, with earnings coming out tomorrow, we would rather look to buy on a pullback. GEF produces and sells industrial packaging products worldwide. It has industrial customers in 40 countries. The company has a great dividend that is protected by a payout of less than 50% of cash flow. We would look to enter this on a pullback to $36. Yield 4.47%
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly This almost makes our Top Pick category. However, with earnings coming out tomorrow, we would rather look to buy on a pullback. GEF produces and sells industrial packaging products worldwide. It has industrial customers in 40 countries. The company has a great dividend that is protected by a payout of less than 50% of cash flow. We would look to enter this on a pullback to $36. Yield 4.47%
INDUSTRIAL PRODUCTS
TOP PICK
TOP PICK
August 20, 2020
Stockchase Research Editor: Michael O'Reilly THO manufacturers RVs in the US, Canada and Europe. One of the trends emerging with the pandemic is for families to travel together and RV sales have benefitted. The company recently released earnings and and EPS was $0.43 versus consensus for a loss of $0.10. Moody's just completed a periodic review of ratings and considers the company to have a competitive standing in North America and Europe. It also pays a reasonable dividend with a payout ratio of less than 45% of cash flow. We would trade this with a stop loss at $95 and an upper target of $120. Yield 1.47%
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly THO manufacturers RVs in the US, Canada and Europe. One of the trends emerging with the pandemic is for families to travel together and RV sales have benefitted. The company recently released earnings and and EPS was $0.43 versus consensus for a loss of $0.10. Moody's just completed a periodic review of ratings and considers the company to have a competitive standing in North America and Europe. It also pays a reasonable dividend with a payout ratio of less than 45% of cash flow. We would trade this with a stop loss at $95 and an upper target of $120. Yield 1.47%
Automotive
TOP PICK
TOP PICK
August 20, 2020
Stockchase Research Editor: Michael O'Reilly ADI designs and manufactures integrated circuits and chips that go into 5G network gear and has sales globally. The company just released earnings and the EPS was $0.97 per share versus expectations of $0.86. The company increased earnings guidance to $1.22-$1.42 per share, while analysts are projecting $1.25 -- this should make it relatively easy to meet next quarter's earnings expectations. It also pays a reasonable dividend. We like the entry level here with a $110 stop loss and a target over $136 -- 16% upside. Yield 2.1% (Analysts’ price target is $136.30)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly ADI designs and manufactures integrated circuits and chips that go into 5G network gear and has sales globally. The company just released earnings and the EPS was $0.97 per share versus expectations of $0.86. The company increased earnings guidance to $1.22-$1.42 per share, while analysts are projecting $1.25 -- this should make it relatively easy to meet next quarter's earnings expectations. It also pays a reasonable dividend. We like the entry level here with a $110 stop loss and a target over $136 -- 16% upside. Yield 2.1% (Analysts’ price target is $136.30)
electrical/electronic
TOP PICK
TOP PICK
August 20, 2020
Stockchase Research Editor: Michael O'Reilly The company doesn't leap to mind as a up and coming rising star, but it is a dividend aristocrat with a strong, and sustainable, dividend. The company is expanding its efforts in AI and cloud based services, including a recent partnership in Korea, where citizens will share health related surveys for policy makers. The company was recently upgraded to a target of $155 -- over 25% upside potentially. We would trade this with a stop loss at $115. Yield 5.26% (Analysts’ price target is $134.06)
Stockchase Research Editor: Michael O'Reilly The company doesn't leap to mind as a up and coming rising star, but it is a dividend aristocrat with a strong, and sustainable, dividend. The company is expanding its efforts in AI and cloud based services, including a recent partnership in Korea, where citizens will share health related surveys for policy makers. The company was recently upgraded to a target of $155 -- over 25% upside potentially. We would trade this with a stop loss at $115. Yield 5.26% (Analysts’ price target is $134.06)